Shenzhen Hepalink Pharmaceutical Group Co., Ltd. (HKG:9989)
Hong Kong
· Delayed Price · Currency is HKD 5.35
-0.03 (-0.56%)
At close: Dec 5, 2025
HKG:9989 Ratios and Metrics
Market cap in millions HKD. Fiscal year is January - December.
Millions HKD. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2015 |
|---|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 4, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 | Dec '20 Dec 31, 2020 | 2019 - 2015 |
| Market Capitalization | 17,739 | 15,060 | 16,905 | 19,320 | 27,970 | 28,112 | Upgrade
|
| Market Cap Growth | 8.69% | -10.92% | -12.50% | -30.93% | -0.50% | 3.28% | Upgrade
|
| Enterprise Value | 17,802 | 16,448 | 21,024 | 22,600 | 29,804 | 30,748 | Upgrade
|
| Last Close Price | 5.35 | 3.73 | 3.37 | 5.02 | 7.44 | 10.64 | Upgrade
|
| PE Ratio | 38.63 | 21.88 | - | 23.49 | 94.63 | 23.11 | Upgrade
|
| PS Ratio | 3.01 | 2.69 | 2.83 | 2.39 | 3.58 | 4.44 | Upgrade
|
| PB Ratio | 1.31 | 1.16 | 1.28 | 1.38 | 1.98 | 2.03 | Upgrade
|
| P/TBV Ratio | 1.68 | 1.49 | 1.66 | 1.81 | 2.62 | 2.71 | Upgrade
|
| P/FCF Ratio | 9.61 | 7.10 | - | - | - | - | Upgrade
|
| P/OCF Ratio | 8.81 | 6.45 | 38.53 | - | - | 634.89 | Upgrade
|
| EV/Sales Ratio | 3.00 | 2.94 | 3.51 | 2.79 | 3.82 | 4.86 | Upgrade
|
| EV/EBITDA Ratio | 20.94 | 15.05 | 180.70 | 15.71 | 22.01 | 20.11 | Upgrade
|
| EV/EBIT Ratio | 33.42 | 20.72 | - | 20.02 | 29.13 | 25.54 | Upgrade
|
| EV/FCF Ratio | 9.64 | 7.75 | - | - | - | - | Upgrade
|
| Debt / Equity Ratio | 0.25 | 0.29 | 0.46 | 0.52 | 0.49 | 0.48 | Upgrade
|
| Debt / EBITDA Ratio | 3.37 | 3.33 | 38.64 | 4.95 | 4.98 | 4.28 | Upgrade
|
| Debt / FCF Ratio | 1.83 | 1.78 | - | - | - | - | Upgrade
|
| Asset Turnover | 0.31 | 0.29 | 0.27 | 0.36 | 0.33 | 0.31 | Upgrade
|
| Inventory Turnover | 0.73 | 0.58 | 0.67 | 0.84 | 1.11 | 1.19 | Upgrade
|
| Quick Ratio | 1.16 | 1.09 | 0.76 | 0.94 | 1.19 | 1.52 | Upgrade
|
| Current Ratio | 2.39 | 2.60 | 2.13 | 2.22 | 2.25 | 2.53 | Upgrade
|
| Return on Equity (ROE) | 3.23% | 5.17% | -6.58% | 5.97% | 2.01% | 10.66% | Upgrade
|
| Return on Assets (ROA) | 2.22% | 2.55% | -0.68% | 3.13% | 2.73% | 3.70% | Upgrade
|
| Return on Capital (ROIC) | 2.44% | 2.80% | -0.75% | 3.46% | 3.02% | 4.07% | Upgrade
|
| Return on Capital Employed (ROCE) | 4.70% | 5.50% | -1.50% | 6.60% | 5.80% | 6.60% | Upgrade
|
| Earnings Yield | 2.59% | 4.57% | -5.10% | 4.26% | 1.06% | 4.33% | Upgrade
|
| FCF Yield | 10.41% | 14.09% | -0.26% | -5.73% | -0.88% | -0.74% | Upgrade
|
| Dividend Yield | 5.05% | 7.13% | - | 2.25% | 0.58% | 1.67% | Upgrade
|
| Payout Ratio | 68.39% | - | - | 34.51% | 171.31% | 43.69% | Upgrade
|
| Buyback Yield / Dilution | 0.56% | 0.54% | -0.67% | -0.05% | -8.42% | -8.51% | Upgrade
|
| Total Shareholder Return | 5.60% | 7.67% | -0.67% | 2.20% | -7.84% | -6.84% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.